Vigadrone Tablet
Product Images NDC 0245-6001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigadrone (NDC 0245-6001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vigadrone 01)

Chemical Structure (Vigadrone 01)
Chemical structure of vigabatrin, showing molecular bonds including an amino group, a vinyl group, and a carboxylic acid functional group.*
FDA Label Image

Figure 1 (Vigadrone 02)

Figure 1 (Vigadrone 02)
A cumulative distribution plot showing the percentage reduction in seizure frequency versus percentage of patients. The graph compares responses to placebo and three doses of vigabatrin (1 g/day, 3 g/day, 6 g/day). Improvement and worsening of seizure frequency are noted with arrows. The lines differentiate the dose groups and placebo, illustrating seizure reduction data.*
FDA Label Image

Figure 2 (Vigadrone 03)

Figure 2 (Vigadrone 03)
A cumulative frequency plot showing percent reduction in seizure frequency versus percent of patients. Two lines represent comparison groups: placebo and 3 g/day vigabatrin. The y-axis ranges from -100% (worsening) to 100% (improvement) with a midpoint of no change at 0%. The x-axis shows percent of patients from 0 to 100.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
VIGADRONE 500 mg oral tablets packaging label, containing vigabatrin as the active ingredient. The label shows a count of 100 tablets in the container, marked for prescription use only. It is manufactured by Upsher-Smith Laboratories, LLC, with instructions for storage between 20° to 25°C and dispensing with a patient medication guide. The label includes barcodes and relevant regulatory and manufacturing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.